Wed, January 29, 2025
Tue, January 28, 2025
Mon, January 27, 2025

India raising the bar on drug formulation challenges

The article from MSN discusses India's significant strides in the pharmaceutical sector, particularly in drug formulation. It highlights how India has become a global hub for generic drugs, with companies like Sun Pharma, Dr. Reddy's Laboratories, and Cipla leading the charge. The piece outlines the challenges faced by the Indian pharmaceutical industry, including stringent regulatory compliance, intellectual property rights issues, and the need for innovation in drug delivery systems. Despite these challenges, India is pushing forward with investments in research and development, aiming to not only produce cost-effective generics but also to develop new formulations and improve drug delivery technologies. The article also touches on the government's role in fostering an environment conducive to pharmaceutical growth through policy support and incentives for R&D. This reflects India's ambition to elevate its status from a generic drug manufacturer to a leader in pharmaceutical innovation.

Read the Full MSN Article at:
[ https://www.msn.com/en-in/science/biochemistry/india-raising-the-bar-on-drug-formulation-challenges/ar-AA1xZ927 ]